JP2007512237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512237A5 JP2007512237A5 JP2006536948A JP2006536948A JP2007512237A5 JP 2007512237 A5 JP2007512237 A5 JP 2007512237A5 JP 2006536948 A JP2006536948 A JP 2006536948A JP 2006536948 A JP2006536948 A JP 2006536948A JP 2007512237 A5 JP2007512237 A5 JP 2007512237A5
- Authority
- JP
- Japan
- Prior art keywords
- ibandronate sodium
- ray
- crystalline form
- reflection
- sodium crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60402604P | 2004-08-23 | 2004-08-23 | |
| US69086705P | 2005-06-16 | 2005-06-16 | |
| PCT/US2005/030500 WO2006024024A2 (en) | 2004-08-23 | 2005-08-23 | Solid and crystalline ibandronate sodium and processes for preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007512237A JP2007512237A (ja) | 2007-05-17 |
| JP2007512237A5 true JP2007512237A5 (https=) | 2008-02-14 |
| JP4559431B2 JP4559431B2 (ja) | 2010-10-06 |
Family
ID=35968334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006536948A Expired - Lifetime JP4559431B2 (ja) | 2004-08-23 | 2005-08-23 | 固体及び結晶イバンドロネートナトリウム及びその調製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7563918B2 (https=) |
| EP (2) | EP1930011B1 (https=) |
| JP (1) | JP4559431B2 (https=) |
| KR (2) | KR20090120011A (https=) |
| CN (1) | CN101022812A (https=) |
| AT (2) | ATE495747T1 (https=) |
| CA (1) | CA2576659A1 (https=) |
| DE (2) | DE602005025977D1 (https=) |
| ES (1) | ES2358269T3 (https=) |
| IL (1) | IL181298A (https=) |
| PT (2) | PT1930011E (https=) |
| WO (1) | WO2006024024A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3395338T (pt) | 2003-09-12 | 2019-07-23 | Amgen Inc | Formulação de dissolução rápida de cinacalcet hcl |
| EP2363401A1 (en) * | 2005-02-01 | 2011-09-07 | F. Hoffmann-La Roche AG | Ibandronate polymorph B |
| RU2368617C2 (ru) * | 2005-02-01 | 2009-09-27 | Ф.Хоффманн-Ля Рош Аг | Полиморфная модификация а ибандроната |
| WO2007074475A2 (en) * | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Novel polymorphic forms of ibandronate |
| WO2008014510A2 (en) * | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Limited | Crystalline form a of ibandronic acid and process for the preparation |
| EP2009016A3 (en) | 2006-11-16 | 2009-02-25 | Teva Pharmaceutical Industries Ltd | Process for preparing crystalline form of ibandronate sodium |
| CA2570949A1 (en) * | 2006-12-12 | 2008-06-12 | Apotex Pharmachem Inc. | Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| BRPI0809548A8 (pt) | 2007-04-11 | 2018-10-16 | Hoffmann La Roche | processo para a preparação do sal ácido- (mono-hidratado)-3- (n-metil-n-pentil) amino-1-hidroxipropano-1, 1-difosfônico monossódico |
| AU2008242788A1 (en) | 2007-04-19 | 2008-10-30 | Dr. Reddy's Laboratories Ltd. | Ibandronate sodium polymorphs |
| WO2009020483A1 (en) * | 2007-08-09 | 2009-02-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of ibandronate sodium |
| EP2128166A1 (en) | 2008-05-20 | 2009-12-02 | Chemo Ibérica, S.A. | Polymorphic forms of Ibandronate sodium and processes for preparation thereof |
| EP2212338B1 (en) * | 2007-10-26 | 2013-07-10 | Chemo Ibérica, S.A. | Polymorphic forms of ibandronate sodium and processes for preparation thereof |
| WO2009061336A1 (en) * | 2007-11-05 | 2009-05-14 | Teva Pharmaceutical Industries Ltd. | Amorphous and crystalline forms of ibandronate disodium |
| EP2180003A1 (en) | 2008-10-21 | 2010-04-28 | Zentiva, k.s. | Preparation of ibandronate trisodium |
| JP5685550B2 (ja) | 2009-02-13 | 2015-03-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用 |
| EP2429390B1 (en) | 2009-05-15 | 2015-09-09 | Nox Medical | System and methods using flexible capacitive electrodes for measuring biosignals |
| WO2011016738A1 (en) | 2009-08-05 | 2011-02-10 | Zaklady Farmaceutyczne Polpharma Sa | A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate |
| LT3494972T (lt) | 2010-01-27 | 2024-03-12 | Viiv Healthcare Company | Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti |
| ES2525844T3 (es) | 2010-06-25 | 2014-12-30 | Nox Medical Ehf. | Conector para correa biométrica |
| PL2753352T5 (pl) | 2010-09-03 | 2022-10-17 | Valneva Austria Gmbh | Izolowany polipeptyd białek toksyny a i toksyny b z c. difficile i jego zastosowania |
| AR085689A1 (es) | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
| WO2013179305A1 (en) * | 2012-06-01 | 2013-12-05 | Hetero Research Foundation | Ibandronate sodium solid dispersion |
| WO2014170909A2 (en) | 2013-04-01 | 2014-10-23 | Hetero Research Foundation | Process for pomalidomide |
| WO2015068041A1 (en) | 2013-11-06 | 2015-05-14 | Nox Medical | Method, apparatus, and system for measuring respiratory effort |
| MY180626A (en) | 2013-11-15 | 2020-12-03 | Akebia Therapeutics Inc | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
| WO2018033889A1 (en) | 2016-08-19 | 2018-02-22 | Nox Medical | Method, apparatus, and system for measuring respiratory effort of a subject |
| US11896386B2 (en) | 2017-06-02 | 2024-02-13 | Nox Medical Ehf | Coherence-based method, apparatus, and system for identifying corresponding signals of a physiological study |
| WO2019049097A1 (en) | 2017-09-08 | 2019-03-14 | Nox Medical Ehf | SYSTEM AND METHOD FOR NON-INVASIVE DETERMINATION OF AN INTERNAL COMPONENT OF RESPIRATORY EFFORT |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| JP2639721B2 (ja) | 1988-12-27 | 1997-08-13 | 富士重工業株式会社 | 内燃機関の燃焼室 |
| US5652227A (en) * | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
| DE19637890A1 (de) * | 1996-09-17 | 1998-03-19 | Max Planck Gesellschaft | Biphosphonat-Liposomen |
| DE19828450A1 (de) * | 1998-06-26 | 1999-12-30 | Hassan Jomaa | Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien |
| EP0998933A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
| EP0998932A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| KR100763064B1 (ko) * | 1999-05-21 | 2007-10-04 | 노파르티스 아게 | 제약 조성물 및 용도 |
| US6677320B2 (en) * | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
| ATE314862T1 (de) * | 2000-05-05 | 2006-02-15 | Hoffmann La Roche | Gelartige pharmazeutische zusammensetzung zur subcutanen anwendung enthaltend bisphosphonsäuren oder deren salze |
| CA2410201C (en) * | 2000-06-20 | 2010-10-26 | Novartis Ag | Zoledronic acid or salts thereof for use in the treatment of conditions of abnormally increased bone turnover |
| GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
| EP1228761A3 (en) * | 2001-02-01 | 2003-01-15 | Riderway Corporation | Liquid pharmaceutical composition for treating bone diseases |
| ITMI20020908A1 (it) | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
| RU2387451C2 (ru) * | 2002-05-10 | 2010-04-27 | Ф.Хоффманн-Ля Рош Аг | Бисфосфоновые кислоты, предназначенные для лечения и профилактики остеопороза |
| TWI282283B (en) * | 2002-05-17 | 2007-06-11 | Wyeth Corp | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| HRP20041013B1 (hr) * | 2002-12-20 | 2013-10-25 | F. Hoffmann - La Roche Ag | Formulacija visoke doze ibandronata |
| CA2551230A1 (en) * | 2003-12-23 | 2005-07-14 | Lyogen Limited | A process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof |
| MX2007000087A (es) * | 2004-06-23 | 2007-11-06 | Teva Pharma | Acido ibandronico solido y cristalino. |
| EP2363401A1 (en) | 2005-02-01 | 2011-09-07 | F. Hoffmann-La Roche AG | Ibandronate polymorph B |
| RU2368617C2 (ru) | 2005-02-01 | 2009-09-27 | Ф.Хоффманн-Ля Рош Аг | Полиморфная модификация а ибандроната |
| WO2007074475A2 (en) | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Novel polymorphic forms of ibandronate |
-
2005
- 2005-08-23 EP EP08002626A patent/EP1930011B1/en not_active Expired - Lifetime
- 2005-08-23 KR KR1020097022363A patent/KR20090120011A/ko not_active Ceased
- 2005-08-23 CA CA002576659A patent/CA2576659A1/en not_active Abandoned
- 2005-08-23 AT AT05791142T patent/ATE495747T1/de not_active IP Right Cessation
- 2005-08-23 EP EP05791142A patent/EP1713489B1/en not_active Revoked
- 2005-08-23 KR KR1020077005922A patent/KR20070043043A/ko not_active Ceased
- 2005-08-23 PT PT08002626T patent/PT1930011E/pt unknown
- 2005-08-23 JP JP2006536948A patent/JP4559431B2/ja not_active Expired - Lifetime
- 2005-08-23 ES ES05791142T patent/ES2358269T3/es not_active Expired - Lifetime
- 2005-08-23 AT AT08002626T patent/ATE520406T1/de not_active IP Right Cessation
- 2005-08-23 CN CNA2005800285039A patent/CN101022812A/zh active Pending
- 2005-08-23 WO PCT/US2005/030500 patent/WO2006024024A2/en not_active Ceased
- 2005-08-23 DE DE602005025977T patent/DE602005025977D1/de not_active Expired - Lifetime
- 2005-08-23 DE DE202005021414U patent/DE202005021414U1/de not_active Expired - Lifetime
- 2005-08-23 PT PT05791142T patent/PT1713489E/pt unknown
-
2006
- 2006-12-22 US US11/644,568 patent/US7563918B2/en not_active Expired - Fee Related
-
2007
- 2007-02-13 IL IL181298A patent/IL181298A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007512237A5 (https=) | ||
| JP2007302683A5 (https=) | ||
| JP2011527299A5 (https=) | ||
| JP2009235100A5 (https=) | ||
| JP2014005302A5 (https=) | ||
| HRP20171175T1 (hr) | Novi triciklički spojevi | |
| JP2018024682A5 (https=) | ||
| JP2023002516A5 (https=) | ||
| RU2013109393A (ru) | Безилатная соль ингибитора втк | |
| FI2629097T1 (fi) | Nrf2-seulontatestejä ja niihin liittyviä menetelmiä ja koostumuksia | |
| HRP20140666T1 (hr) | Kristalni oblici derivata 2-tiazolil-4-kinolinil-oksi, snažnog hcv-inhibitora | |
| JP2013509429A5 (https=) | ||
| JP2009545527A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| JP2014523445A5 (https=) | ||
| JP2010513478A5 (https=) | ||
| HRP20181048T1 (hr) | Neuroaktivni 19-alkoksi-17-supstituirani steroidi, korisni u postupcima liječenja | |
| HRP20150584T1 (hr) | Soli i polimorfi tetraciklinskog spoja | |
| JP2011500621A5 (https=) | ||
| JP2013542247A5 (https=) | ||
| HRP20130026T1 (hr) | Kristalni oblik posakonazola | |
| HRP20140004T1 (hr) | Novi spojevi 951: bifeniloksipropanska kiselina kao crth2 modulator i intermedijeri | |
| NZ592383A (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
| JP2008518904A5 (https=) | ||
| HRP20150062T1 (hr) | Farmaceutski pripravak koji sadrži optički aktivan spoj koji sadrži agonist receptora trombopoietina i njegov međuprodukt |